Like, I've seen patients with vague, intermittent 'dizziness,' that actually has been happening for months. It's always: 'OMG. What's wrong with me? This is so strange; better go to the ER.' But on the other hand, some people wake up and their arm doesn't work, and they're like, 'Hmm, maybe I can ride this one out.' - u/noteasybeincheesy
One day my left foot hurt for no good reason. I stood up to shake off the pain and tweaked my right Achilles tendon, so I headed for the medicine cabinet, bent over like an ape because of a stiff back. Actually, I lied. It wasn't one day. It's pretty much every day.
Go for a run, watch a film, try to entertain someone else's baby: anything that involves pottering about in an undemanding yet still vaguely engaged way, which absolutely couldn't be classed as work but isn't totally vegetative either. It may not be the productivity hack any go-getter wants to hear, but it's surprising how often a spell of aimless noodling around frees an otherwise overworked human brain to make the kind of lateral mental leap that helps everything fall into place.
When Dan Richards went for a New Year's Eve swim in 2023, he never could have imagined how drastically his life would change. In a freak accident, he injured his neck when a wave caused him to flip and hit the sand in Langland Bay, Swansea. "I knew instantly that I was paralysed," the 37-year-old said. "I couldn't move anything." Doctors told him he would be bed-bound but, two years later, he uses a wheelchair and can move his arms and fingers.
Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively by healthcare research firm 3 Axis Advisors. The number of price increases for 2026 is up from the same point last year, when drugmakers unveiled plans for raises on more than 250 drugs.
The researchers assessed the quality of their sleep across five dimensions in 27,500 middle-aged and elderly people (average age 54.7 years) enrolled in the UK Biobank (a research institute conducting long-term follow-up studies of the effects of genetic predisposition and lifestyle on disease). Approximately nine years later, they scanned the participants' brains with MRI and used machine learning models to estimate their biological brain age.
Now, scientists have detected two new biological strands of MS using AI, a simple blood test and MRI scans. Experts said the exciting breakthrough could revolutionise treatment of the disease worldwide. In research involving 600 patients, led by University College London (UCL) and Queen Square Analytics, researchers looked at blood levels of a special protein called serum neurofilament light chain (sNfL).
Extraordinary medical cases-even the grisly and disturbing ones-offer a reprieve from the onslaught of current events and the stresses of our daily lives. With those remarkable reports, we can marvel at the workings, foibles, and resilience of the human body. They can remind us of the shared indignities from our existence in these mortal meatsacks. We can clear our minds of worry by learning about something we never even knew we should worry about-or by counting our blessings for avoiding so far.
Occasionally, we'll see an ad or hear about something in what I would call the wellness-industrial complex (companies eager to earn a buck on people by sending lab tests that have dubious clinical significance and then selling the customer a cure, a panacea, or a longevity or athleticism cheat code), and he'll become surprisingly resentful and woeful about the entire concept of medicine, complaining that it offers him nothing because it only treats diseases rather than offering enhancements that could make him, essentially, superior to a typical disease free human (superhuman?).
I don't look at it as too far different from any other kind of extreme challenge where conventional wisdom will tell you that this doesn't make a whole lot of sense," Siddiqi said. "The process of actually achieving it I think can have significant physical and mental impact and can reshape your view of yourself or your view of your capabilities or your understanding of your body and its limitations," he added.
CGMP stands for "Current Good Manufacturing Process," which are FDA guidelines put in place for a product's safety. This includes where and how it was made, as well as what it was made of. But even with this kind of baseline, it's hard to tell what additives are used in a supplement and how that can counteract its effects or react with your body chemistry.
One user asked, "Now what made you say, let me go put some makeup on?" Another chimed in, "Why are people so afraid of aging?" Mostly, though, people questioned why someone would undergo such an intense procedure in the first place. Was this an example of skin care culture gone too far, or a part of dermatologic care that actually delivers results?
"REPORTS A BAG OF MARIJUANA HAS BEEN IN HER VAGINA FOR 2 DAYS AND IS UNCOMFORTABLE" BRACELET CHARMS 2 VIBRATORS 2 PENIS RING "WAS USING A PIECE OF PLASTIC TO MASTURBATE WHEN GOT SPOOKED BY THE WIND OUTSIDE AND THREW THE SHEET OVER HERSELF IN THE PROCESS LODGING THE PIECE OF PLASTIC DEEPER INTO HER VAGINA AND WASN'T ABLE TO RETRIEVE" DETERGENT POD PLUNGER CAP BEER BOTTLE, "WAS ON A CRUISE ON HER HONEYMOON"
The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly. The pill is 25 milligrams of semaglutide, the same active ingredient in injectable Wegovy and Ozempic, and will be sold under the brand name Wegovy. Novo already sells an oral semaglutide for type 2 diabetes, Rybelsus.
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly's oral drug, orforglipron, is still under review. Both pills are GLP-1 drugs that work like widely used injectables to mimic a natural hormone that controls appetite and feelings of fullness.
The big picture: The Danish drugmaker said participants in a 64-week clinical trial saw an average weight loss of about 17% if they stayed on the daily pill, reduced their calorie intake and increased exercise. That's compared to 3% average weight loss among trial participants who received a placebo. Between the lines: The active ingredient in oral Wegovy will be manufactured in North Carolina, Novo Nordisk said.
64-year-old Pamela Mansfield sways her feet to the rhythm of George Jones' "She Thinks I Still Care." Mansfield is still recovering much of her mobility after a recent neck surgery, but she finds a way to move to the music floating from a record player that was wheeled into her room. "Seems to be the worst part is the stiffness in my ankles and the no feeling in the hands," she says. "But music makes everything better."
Thirteen major hospitals will use a device that cleans patients' blood that has become corrupted by toxins as a result of them developing acute-on-chronic liver failure (ACLF). ACLF is a severe and hard-to-treat form of liver disease linked to obesity, alcohol and hepatitis, in which patients suddenly deteriorate and have to be admitted to intensive care. Three out of four people affected are only diagnosed when it has already become life-threatening.
A popular myth is that you should try to suck out the venom, but that can actually make things worse, according to Jared Ross, a board-certified emergency medicine physician and professor at the University of Missouri. Ross explains that sucking doesn't create enough suction to remove venom and instead increases blood flow to the area, which can cause the venom to spread.
If President Donald Trump wanted Americans to take away one message about autism, it was this: Blame Tylenol. During his September press conference on the subject, Trump warned pregnant women more than a dozen times not to take the drug, even though two massive studies had found no meaningful association with the disorder in children. He also spread false rumors that "essentially no autism" can be found in Cuba or among the Amish.
Whatever mixture of genetics, temperament, trauma, and environment leads someone to use cannabis daily, such frequency almost inevitably results in addiction, that seemingly mysterious bending of the will and reward toward continued cannabis use despite adverse consequences. For example, money might be rewarding as a means to buy more cannabis, but no longer be very rewarding in and of itself. Or being high might become more desired than good grades or excelling at sports. The mind bends toward getting high as its preferred state.
In 2035, AIs are more than co-pilots in medicine, they have become the frontline for much primary care. Gone is the early morning scramble to get through to a harassed GP receptionist for help. Patients now contact their doctor's AI to explain their ailments. It quickly cross-checks the information against the patient's medical history and provides a pre-diagnosis, putting the human GP in a position to decide what to do next.
Maura Derrane has been on our screens for three decades and has spent the last 14 co-hosting the 'Today' show with Dáithí Ó Sé - she talks to Kirsty Blake Knox about the programme's success and why Christmas is hard after losing her sister to cancer For many experiencing grief and loss, Christmas can be a challenging time. And that's something broadcaster Maura Derrane knows well.
A pathologist studies an extremely thin slice of human tissue under a microscope, searching for visual signs that reveal whether cancer is present and, if so, what type and stage it has reached. To a trained specialist, examining a pink, swirling tissue sample dotted with purple cells is like grading a test without a name on it -- the slide contains vital information about the disease, but it offers no clues about who the patient is.
